Amgen Inc.AMGN
NasdaqGS•Healthcare•Drug Manufacturers - General
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $37.22B, growing 9.1% year-over-year. TTM net income stood at $7.80B (31.5% growth). Quarterly EBITDA was $3.78B and operating income was $2.67B. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze AMGN growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters